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Abstract: Isatis tinctoria L. (Brassicaceae), which is commonly known as woad, is a species with an
ancient and well-documented history as an indigo dye and medicinal plant. Currently, I. tinctoria
is utilized more often as medicinal remedy and also as a cosmetic ingredient. In 2011, I. tinctoria
root was accepted in the official European phytotherapy by introducing its monograph in the
European Pharmacopoeia. The biological properties of raw material have been known from
Traditional Chinese Medicine (TCM). Over recent decades, I. tinctoria has been investigated both
from a phytochemical and a biological point of view. The modern in vitro and in vivo scientific
studies proved anti-inflammatory, anti-tumour, antimicrobial, antiviral, analgesic, and antioxidant
activities. The phytochemical composition of I. tinctoria has been thoroughly investigated and the
plant was proven to contain many valuable biologically active compounds, including several alkaloids,
among which tryptanthrin, indirubin, indolinone, phenolic compounds, and polysaccharides as
well as glucosinolates, carotenoids, volatile constituents, and fatty acids. This article provides a
general botanical and ethnobotanical overview that summarizes the up-to-date knowledge on the
phytochemistry and biological properties of this valuable plant in order to support its therapeutic
potential. Moreover, the biotechnological studies on I. tinctoria, which mainly focused on hairy root
cultures for the enhanced production of flavonoids and alkaloids as well as on the establishment
of shoot cultures and micropropagation protocols, were reviewed. They provide input for future
research prospects.
Keywords: alkaloids and flavonoids; anti-inflammatory; anti-tumour; antiviral; antioxidant;
Brassicaceae; hairy roots; woad
1. Introduction
The genus Isatis L., which belongs to the Brassicaceae family, comprises about 80 herbaceous annual
to perennial species diffused in the Middle East and central Asia and extending to the Mediterranean
region [1–3].
Plants 2020, 9, 298; doi:10.3390/plants9030298 www.mdpi.com/journal/plants
Plants 2020, 9, 298 2 of 40
Isatis tinctoria L., which is commonly known as woad, is an herbaceous biennial or short-lived
perennial species [1,2]. This species is thought to be native of Central Asia, as confirmed by genetic
analyses [4,5], even though other authors report it as native to South-eastern Russia to South-west Asia
and, perhaps, to some parts of South-eastern Europe [2,6].
Currently, it is a common ruderal plant of dry and sunny locations and it grows spontaneously
in the rocky substrates, abandoned crops, open woods, clearings, and along the roads. It is very
widespread from the sea level up to the maximum altitude of 1900 meters and it usually prefers hot
spots and nitrogen-rich limestone soils [7,8]. It is considered a noxious weed in most of the Western
United States [9].
I. tinctoria has a long and well-documented history for its medicinal properties and its indigo
blue colour. This double use of woad is shown by its name. On one hand, the term “Isatis” that
derives from the latin word “Isazein” and the greek word “Isadso” is linked to the its ancient use to
treat wounds [10]. On the other hand, the term “tinctoria” refers to the use that was done in the dye
works [8].
This species was introduced in Europe in late Prehistory and Protohistory periods, as confirmed
by the discovery of textile remains dyed in blue and preserved from the Neolithic, Bronze, and Iron
Ages [11]. The ancient Egyptians used I. tinctoria as an indigo source to dye the cloth wrappings
applied for the mummies [12].
Historical accounts about the use of indigo in Europe date back to Roman times. Historical sources
report that Celtic and Germanic people used woad to paint their body and hair for prophylactic or
ritual purposes.
Pliny the Elder often mentioned woad in its writings, and reported the custom of female Britons
covering their bodies with indigo blue for religious ceremonies [13]. Julius Caesar reported in his
book De Bello Gallico that the Celtic populations used woad indigo to colour themselves to generate a
fearsome appearance [14]. They pricked their skin and rubbed woad on to form a blue tattoo. The
Romans called these people Picti, which means “painted people” [13]. This suggests that the I. tinctoria
dye may have been used both for textile and body art [11].
From the 12th up to the 17th century, I. tinctoria has been widely cultivated in Europe (Germany,
France, England, and Italy), and extensively used as indigo dye and medicinal plant. In the early 17th
century, I. tinctoria was intentionally taken from Europe into North America by early colonists as a
textile dye crop [6,15]. In the late 17th century, the decline of the woad industry in Europe was initiated
due to the import of indigo blue from Indigofera tinctoria cultivated in Asia (India, Bangladesh) and,
afterward, from other Indigofera species in the Caribbean and the American colonies, which was easier
and more economical to extract. The crop was definitively abandoned in the late 19th century, when
the production of synthetic dyes completely replaced natural indigo production [5,14,16]. With the
declining importance as a dye and the disappearance of woad cultures, the plant also fell into oblivion
as a medicinal plant [6,17].
Currently, I. tinctoria is widely utilized for medicinal purposes in the Traditional Chinese Medicine
(TCM) [6,18,19] and, from the 2011 year, it is recognized as a pharmacopoeial plant in Europe [20].
Currently, I. tinctoria is utilized in cosmetic industries for the production of soaps and body creams.
The seed oil and the leaves (powder/extract) are cosmetic ingredients for skin and hair conditioning
due to their emollient and moisturising properties [5]. The roots (powder/extract) have astringent
and skin protecting properties. The CosIng Database elaborated by the European Commission gives
positivity to these previously mentioned raw materials for the production of cosmetics in Europe [21].
In recent years, renewed interest in natural dyes showed by the dyestuff industry and its potential
use for medicinal and cosmetic products has encouraged growers to reintroduce I. tinctoria crops in the
European agricultural system [5,22]. Horticulturists have become interested in utilizing I. tinctoria as
an ornamental plant because of its tolerance to heat and water stresses, a long flowering period, and
attractive inflorescences [10].
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Currently, although this species is not considered an edible vegetable worldwide, rural people
living in Sicily (Italy) around Vulcan Etna consume boiled flower buds of this plant as ingredients for
salads and omelettes [10,23].
Due to the relevance of I. tinctoria, in recent decades, a considerable number of phytochemical
and biological investigations on this species have been carried out. A previous review article by
Hamburger [6] reported the studies published from 2000 to 2002 on the anti-inflammatory activity of
I. tinctoria extract and its active component tryptanthrin.
The aim of this article is to provide an up-to-date and comprehensive overview of the ethnobotany,
phytochemistry, and the biological properties demonstrated for this valuable species in order to support
its therapeutic potential and to provide input for future research prospects. The article also focuses on
all attempts in plant biotechnology studies for the enhanced production of flavonoids and alkaloids
from hairy root cultures as an alternative to plant raw materials, but also on the early result about the
establishment of shoot cultures and micropropagation protocols.
2. Botanical Description
Isatis tinctoria L. (woad) is an herbaceous biennial or short-lived perennial species, more or less
hairless to hairy, greyish with an erect stem, up to 120 cm in height, simple below, and branched above
(Figure 1).Plants 2020, 9, x FOR PEER REVIEW 4 of 43 
 
 
Figure 1. Isatis tinctoria L. 
3. Ethnobotanical Uses 
I. tinctoria has a long and well documented history as a medicinal plant in both Eastern and 
Western cultures. Its therapeutic properties have been esteemed in Europe and in Traditional Chinese 
Medicine (TCM) for centuries.  
The first written records in Europe about the medicinal uses of this plant were by Hippocrates 
(460 b.C.) who supported its use for treating wounds, ulcers, and haemorrhoids. Galen (129–216 b.C.) 
and Pliny (23–79 b.C.) recommended it as well [6,28].  
Due to the huge cultivation in Europe for the production of indigo dye, from the 12th century 
until the 17th century, I. tinctoria was also extensively used as a medicinal plant to treat snake bites, 
wounds, and other inflammatory ailments [6,29]. These medicinal properties have been widely 
described in a number of Renaissance and Baroque herbal texts, which recommended woad for 
treating haemorrhoids, ulcers, and tumours [6].  
Various authors have mentioned different medicinal uses for I. tinctoria leaves and roots. The 
leaves have been utilized in the treatment of typhoid, measles, and the flu [30]. Garland [31] reported 
their use against the tremendous inflammation of the skin due to St. Anthony’s fire, which is a 
dreaded illness that was common in the Middle Ages. Other uses such as treating iposideremic 
anaemic diseases (due to iron deficiency), scurvy, and, in general, hypovitaminosis have been 
correlated to the relevant levels of iron, and of vitamins A and C present in the leaves. Moreover, the 
leaf extracts have been used for their anabolic, astringent, and detergent properties. According to 
these skills, the extracts were utilized in treating acrodermatitis, haemorrhagic diathesis, eczema from 
scrofulous, furunculosis, intoxications, hypercholia, jaundice, gastric neurosis, hives, torpid sores, 
scrofulous, heartburn, and seborrhoea [32].  
The bitter and refreshing roots have been utilized to reduce scarlet fever. The root extracts have 
been used to treat patients with solid tumours and leukaemia, which is a traditional usage that led to 
purification of indirubin [9]. 
After I. tinctoria lost its importance as a source of indigo for dying, its curative properties in 
Europe fell into oblivion. It has only just recently emerged into Western awareness as having 
medicinal properties, which is mostly due to its antiviral properties [28]. The European 
Pharmacopoeia currently reports the monograph of I. tinctoria root (Isatidis radix) for use in official 
European phytotherapy [24]. 
In China, woad has an equally rich history as dye and a medicinal plant. The Chinese 
Pharmacopoeia reports three monographs for I. tinctoria: Băn Lán Gēn (Isatidis radix), Dà Qīng Yè 
The r ot is cylindrical, slightly tortuous, externally greyish-yellow, or brownish-yellow, wrinkled
longitudinally and lenticellate transversally, with rootlets or rootlet scars. Root stock slightly expanded,
which exhibited dark green or dark brown petiole bases arranged in whorls, and dense tubercles. Basal
leaves are oblong-lanceolate, entire to toothed, and long-petioled. Cauline leaves, which are narrower
than basal and gradually reduced upwards, are simple, entire, sagittate, usually amplexicaul, with
acute auricles. The flowers are gathered in a racemose inflorescence, with yellow petals, tetradynamous
androecium, consisting of six stamens with two filaments shorter than the others. Fruits are pendulous
siliques, oblong-obovate, or elliptic-obovate hairless or shortly hairy. This species is very variable,
particularly in the size, shape, and hairiness of the silique [1,2,13,24].
There are conflicting views on the taxonomy of I. tinctoria (European woad) and I. indigotica
(Chinese woad). The latter was described for the first time by Fortune in 1846, and initially considered
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as a distinct species. Afterward, some taxonomists have classified it as a variety of I. tinctoria [17].
Angelini et al. [25] reported that I. indigotica presents morphological, genetic, and physiological
differences with respect to the European I. tinctoria, even though it is closely related to this one. The
seedlings of both species develop a rosette in the first year of their cycle. The leaves I. indigotica
show a glaucous instead of a shiny surface, which is rarely pubescent with a greater thickness and a
more upright habit. The high degree of genetic diversity between the two species was confirmed by
various studies [26,27]. Despite this, I. indigotica is currently considered a synonym of I. tinctoria, and
not a separate species, as confirmed by the consulted taxonomic databases known as The Plant List,
International Plant Names Index (IPNI), and Tropicos. On the other hand, the Euro+Med PlantBase
does not mention I. indigotica in the list of synonyms.
3. Ethnobotanical Uses
I. tinctoria has a long and well documented history as a medicinal plant in both Eastern and
Western cultures. Its therapeutic properties have been esteemed in Europe and in Traditional Chinese
Medicine (TCM) for centuries.
The first written records in Europe about the medicinal uses of this plant were by Hippocrates
(460 b.C.) who supported its use for treating wounds, ulcers, and haemorrhoids. Galen (129–216 b.C.)
and Pliny (23–79 b.C.) recommended it as well [6,28].
Due to the huge cultivation in Europe for the production of indigo dye, from the 12th century until
the 17th century, I. tinctoria was also extensively used as a medicinal plant to treat snake bites, wounds,
and other inflammatory ailments [6,29]. These medicinal properties have been widely described in a
number of Renaissance and Baroque herbal texts, which recommended woad for treating haemorrhoids,
ulcers, and tumours [6].
Various authors have mentioned different medicinal uses for I. tinctoria leaves and roots. The
leaves have been utilized in the treatment of typhoid, measles, and the flu [30]. Garland [31] reported
their use against the tremendous inflammation of the skin due to St. Anthony’s fire, which is a dreaded
illness that was common in the Middle Ages. Other uses such as treating iposideremic anaemic diseases
(due to iron deficiency), scurvy, and, in general, hypovitaminosis have been correlated to the relevant
levels of iron, and of vitamins A and C present in the leaves. Moreover, the leaf extracts have been
used for their anabolic, astringent, and detergent properties. According to these skills, the extracts
were utilized in treating acrodermatitis, haemorrhagic diathesis, eczema from scrofulous, furunculosis,
intoxications, hypercholia, jaundice, gastric neurosis, hives, torpid sores, scrofulous, heartburn, and
seborrhoea [32].
The bitter and refreshing roots have been utilized to reduce scarlet fever. The root extracts have
been used to treat patients with solid tumours and leukaemia, which is a traditional usage that led to
purification of indirubin [9].
After I. tinctoria lost its importance as a source of indigo for dying, its curative properties in
Europe fell into oblivion. It has only just recently emerged into Western awareness as having medicinal
properties, which is mostly due to its antiviral properties [28]. The European Pharmacopoeia currently
reports the monograph of I. tinctoria root (Isatidis radix) for use in official European phytotherapy [24].
In China, woad has an equally rich history as dye and a medicinal plant. The Chinese
Pharmacopoeia reports three monographs for I. tinctoria: Băn Lán Gēn (Isatidis radix), Dà Qı̄ng
Yè (Isatidis folium), and Qing Dai (Indigo naturalis) [9,33]. These herbal preparations are considered as
somewhat differing medicines.
Băn Lán Gēn (Isatidis radix) is the dried root of I. tinctoria harvested in some provinces of R.P.
China such as Hebei, Jiangsu, and Anhui during the autumn, dried in the sun, and processed into
granules (Banlangen Keli). The product is very popular throughout China and it is most commonly
consumed when dissolved in hot water or tea [34]. It reduces the body temperature and soothes
the sore throat. It is indicated for eruptive epidemic diseases, pharyngitis, laryngitis, scarlet fever,
erysipelas, and carbuncles. It is utilized for treating hepatitis, mumps, the flu, mononucleosis, viral skin
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diseases such as herpes simplex, herpes zoster, and pityriasis rosea, epidemic cerebrospinal meningitis,
and diphtheria [34–37]. Băn Lán Gēn has been one of the eight major medicines recommended by the
Chinese government for preventing and controlling the deadly severe acute respiratory syndrome
(SARS) [38].
Dà Qı̄ng Yè (Isatidis folium) consists of I. tinctoria dried leaves [39] collected in the summer and
the autumn from different provinces of R.P. China such as Hebei, Jiangsu, Anhui, and Henan and
dried in the sun. Dà Qı̄ng Yè is used against the virus of B-encephalitis, mumps, and influenza and for
treating the leptospirosis [36].
Qing Dai (Indigo naturalis) is a dark blue powder prepared from the leaves of various plants
including I. tinctoria, Baphicacanthus cusia (Nees) Bremek., Indigofera suffruticosa Mill., Indigofera tinctoria
L., or Polygonum tinctorium Ait. It is used in TCM as a haemostatic, antipyretic, anti-inflammatory, and
in the treatment of bacterial and viral infections [40,41].
Another preparation, called Dang Gui Long Hui Wan, consisting of 11 herbal medicines including
I. tinctoria, has been used in TCM as a remedy for various chronic diseases including chronic myelocytic
leukaemia [14].
Clinical trials have not assessed the safety of I. tinctoria leaf or root preparations. Traditional
Chinese herbal texts do not list adverse effects, except gastro-intestinal disorders such as nausea and
vomiting in some patients [36,42].
4. Chemical Composition
I. tinctoria, like other species belonging to the Brassicaceae family, shows an interesting chemical
profile characterized by a large variety of compounds. I. tinctoria represents a valuable source
of bioactive compounds such as alkaloids, phenolic compounds, polysaccharides, glucosinolates,
carotenoids, volatile constituents, and fatty acids (Table 1).
Table 1. Phytochemical composition of I. tinctoria L.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
Alkaloids Tryptanthrin Japan Dried rosetta leavesChloroform [43]
Isatin France
Fresh Leaves
Acetone/acetic acid
1% v/v
[44]
Isatan A – B – C
Isoindigo
Indoxyl
Indicant
cis/trans Indirubin
cis/trans Indigo
(E)-3-(3’,5’-Dimethoxy-4’-hydroxy-benzylidene)-
2-Indolinone Germany
Dried rosette leaves
Dichloromethane [33]
5-Hydroxyoxindole
3-(2’-Carboxyphenyl)quinazolin-4-one
Bisindigotin
Deoxyvasicinone
N-formyl anthranilic acid Germany Dried rosette leavesMethanol [33]
Acetylindican-carboxyl acid France
Frozen and
lyophilized rosette
leaves
Methanol
[16]
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Table 1. Cont.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
6-Hydroxyindolone-3-carboxylic acid 6-O-glucoside France
Frozen and
lyophilized/dried
rosette leaves
Methanol and
Dichloromethane
[45]
6-Hydroxyindolone-3-carboxylic acid glucose ester
Acetylindican
Malonylindican
Dioxindole glucoside
Dyhydroascorbigen
Flavonoids and
their conjugates Vicenin-2 Germany
Dried rosette
leaves, Methanol [33]
Stellarin-2
Isoorientin
Isovitexin
Isoscoparin
Isoorientin-3”-O-glucoside
Isovitexin-3”-O-glucoside
Isoscoparin-3”-O-glucoside
Isoscoparine Germany Dried rosette leavesDichloromethane [33]
Luteolin-6-C-glucoside-7-O-glucoside France
Frozen and
lyophilized rosette
leaves
Methanol
[16]
Vicenin-2
Stellarin-2
Isovitexin
Isovitexin-3”-O-glucoside
Isovitexin-3”-O-glucoside-7-O-glucoside
Isoorientin
Isoorientin-3”-O-glucoside
Iscoscoparin
Isoscoparin-3”-O-glucoside-7-O-glucoside
Iscoscoparin-3”-O-glucoside
4’-O-Feruloyl
iscoscoparin-3”-O-glucoside-7-O-glucoside
2”-O-Feruloyl
isoscoparin-3”-O-glucoside-7-O-glucoside
Isoscoparin-3”-O-glucoside-7-O-feruloylglucoside
Isoscoparin-3”-O-p-coumaroylglucoside
Isoscoparin-3”-O-sinapoylglucoside
Isoscoparin-3”-O-feruloylglucoside
Chrysoeriol-7-O-glucoside
Luteolin glucuronide Italy
Lyophilized
cauline leaves
70% Methanol
[46]
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Table 1. Cont.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
Rutin
Vicenin-2
Bluddleoside
Stellarin-2
Flavone-di-glucoside
Apigenin-di-glucoside
Isovitexin
Quercetin
Isoscoparin
Isoscoparin-di-glucoside
Kaempferol
Apigenin-glucoside
Luteolin- glucuronide Italy
Lyophilized rosette
leaves
70% Methanol
[47]
Vicenin-2
Stellarin-2
Flavone-di-glucoside
Apigenin-glucoside
Apigenin-di-glucoside
Isovitexin
Quercetin
Isoscoparin
Luteolin-glucuronide Italy
Lyophilized
cauline leaves
70% Methanol
[47]
Flavone-di-glucoside
Vicenin-2
Buddleoside
Stellarin-2
Apigenin-glucoside
Apigenin-di-glucoside
Isovitexin
Quercetin
Isoscoparin
Luteolin-glucuronide Italy
Lyophilized
flowers
70% Methanol
[47]
Vicenin-2
Stellarin-2
Apigenin-di-glucoside
Isovitexin
Quercetin
Phenolic acids
and their
conjugates
p-Hydroxybenzoic acid Dried leaves,Methanol [48]
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Table 1. Cont.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
o-Methoxybenzoic acid
p-Methoxybenzoic acid
Dihydrocaffeic acid
4-Hydroxy-3-methoxyphenylpropanoic acid
Sinapic acid Germany
Dried rosette
leaves,
Dichloromethane
[33]
Ferulic acid
Neochlorogenic acid Italy
Lyophilized
cauline leaves
70% Methanol
[46]
Chlorogenic acid
Caffeic acid
Coumarylquinic acid
Sinapic acid
Ferulic acid
p-Coumaric acid
Protocatechuic acid hexoside France
Frozen and
lyophilized rosette
leaves,
Methanol
[16]
Protocatechoyl glucose
p-Coumaroyl glucaric acid
p-Coumaric acid hexoside
p-Coumaroyl dihexoside
p-Coumaroyl hexoside
p-Coumaroyl sinapoyl glucaric acid
di-p-Coumaroyl glucaric acid
Feruloyl dihexoside
Feruloyl glucaric acid
Diferuloyl glucaric acid
Feruloyl glicerate
Feruloyl sinapoyl glucaric acid
Feruloyl p-coumaroyl glucaric acid
Sinapoyl hexoside
Sinapoyl gentiobioside
Sinapoyl glucaric acid
Disinapoyl glucaric acid
Sinapoyl malate
Disinapoyl methoxyglucaric acid
Disinapoyl hexoside
Guaiacyl(8-O-4)feruloyl sinapoyl glucarid acid
Neochlorogenic acid Italy
Lyophilized rosette
leaves
70% Methanol
[47]
Caffeic acid
Sinapic acid
Plants 2020, 9, 298 9 of 40
Table 1. Cont.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
Ferulic acid
Neochlorogenic acid Italy
Lyophilized
cauline leaves
70% Methanol
[47]
Caffeic acid
Sinapic acid
Ferulic acid
Caffeic acid Italy
Lyophilized
flowers
70% Methanol
[47]
Ferulic acid
Monolignols
and oligolignols Syringe France
Frozen and
lyophilized rosette
leaves
Methanol
[16]
Coniferin
Pinoresinol dihexoside
Syringaresinol hexoside
Isodihydrodehydrodiconiferyl alcohol hexoside
Isodihydrodehydrodiconiferyl alcohol dihexoside
5-Hydroxy-coniferyl alcohols hexoside
Syringyl(8-5)guaiacyl hexoside
Guaiacyl(8-5)guaiacyl hexoside
Guaiacyl(erythro8-O-4)guaiacyl hexoside
Guaiacyl(threo8-O-4)guaiacyl hexoside
Guaiacyl(threo8-O-4)dihydroguaiacyl hexoside
Guaiacyl(threo 8-O-4)syringyl(8-5)guaiacyl hexoside
Alifatic
Glucosinolate Epiprogoitrin Germany
Frozen and
lyophilized rosette
leaves
70% Methanol
[49]
Progoitrin
Gluconapin
Indolic
Glucosinolates Glucobrassicin Germany
Frozen and
lyophilized rosette
leaves
70% Methanol
[49]
Neoglucobrassicin
Sulfoglucobrassicn
4-Hydroxyglucobrassicin
Glucotropaeolin
Glucoisatisin/epiglucoisatisin Germany SeedAqueous [50]
Gluconapoleiferin France
Frozen and
lyophilized rosette
leaves
Methanol
[16]
Glucoibericin Italy
Lyophilized rosette
and cauline leaves,
flowers
70% Methanol
[47]
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Table 1. Cont.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
4-Methoxyglucobrassicin Italy Flower70% Methanol [47]
Carotenoids (all-E)-β-Carotene Germany Dried rosette leavesDichloromethane [33]
(13Z)-or (13’Z)- Lutein mixture Germany
Dried rosette leaves
Hexane/Acetone
(1:1)
[33]
(all-E)-Lutein
(9Z)-Lutein
(9’Z)-Lutein
(15Z)-β-Carotene
(9Z)-β-Carotene
(Z)-Neochrome
(15Z)-Violaxantin
(all-E)-Neochrome
(di-Z)-Violaxantin
Porphyrins 10-Hydroxy phaeophorbide Germany Dried rosette leavesDichloromethane [33]
Phaephorbide a
Phaephorbide a’
Pyrophaeophorbide a
Isothiocyanates
and thiocyanates 2-Hydroxy-3-butenyl isothiocyanate Italy
Fresh leaves
HS-SPME [19]
3-Butenyl isothiocyanate
Allyl isothiocyanate
Pentyl isothiocyanate
3-Methylthiopropyl isothiocyanate
Hexyl isothiocyanate
Benzyl isothiocyanate
Methyl thiocyanate
3-Butenyl isothiocyanate Italy Dried rootsHS-SPME [51]
Ciclopentyl isothiocyanate
Methyl thiocyanate
Aldehydes 3-Methylbutanal Italy Fresh leavesHS-SPME [19]
But-2-enal
Hexenal
trans-Pent-2-enal
trans-Hex-2-enal
Nonanal
trans, trans-Hexa-2,4-dienal
trans-Oct-2-enal
trans, trans-Hepta-2,4-dienal
Benzenecarbaldehyde
cis, trans-Nona-2,6-dienal
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Table 1. Cont.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
4-Ethylbenzenecarbaldehyde
Tetradecanal
Furfural Italy Dried rootsHS-SPME [51]
Benzaldehyde
Sulfurated
compounds 2-Ethylthiophene Italy
Fresh leaves
HS-SPME [19]
Carbonyl sulphide
Carbon disulphide
Cyclopenthanethiol
Thiophene
Alcohols Tetradecan-1-ol Italy Fresh leavesHS-SPME [19]
2-Cyclopentylethanol
Butan-1-ol
cis-Pent-2-en-1-ol
trans-Hex-3-en-1-ol
2-Butyloctan-1-ol
Pentadecan-1-ol
Heptadecan-1-ol
2-Methylexadecan-1-ol
Nonadecan-1-ol
Hexanol Italy Dried rootsHS-SPME [51]
1-Octen-3-ol
Heptanol
Furfuryl alcohol
2-Penylethyl alcohol
Phenol
Terpenes and
Sesquiterpenes Limonene Italy
Fresh leaves
HS-SPME [19]
Sabinene
δ-3-Carene
Eucalyptol
γ-Terpinene
p-Cymene
Terpinolene
Myrtenal
p-Cymenene
β-Cyclocitral
Valencene
δ-Cadinene
Geranyl acetone
6-Methyl-5-hepten-2-one Italy Dried rootsHS-SPME [51]
Camphor
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Table 1. Cont.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
Geranyl acetone
Guaiacol
Acids Acetic acid Italy Fresh leavesHS-SPME [19]
Octanoid acid
Butyric Italy Dried rootsHS-SPME [51]
Octanoic acid
Esters Methyl-2-hydroxybenzoate Italy Fresh leavesHS-SPME [19]
Butyl tetradecanoate
Methyl butyrate Italy Dried rootsHS-SPME [51]
Ethers 1-Methoxy-4-prop-2-enylbenzene Italy Fresh leavesHS-SPME [19]
Dyphenil ether
Furans 2-Ethylfuran Italy Fresh leavesLeaf HS-SPME [19]
Hydrocarbons trans-1,5-Heptadiene Italy Fresh leavesHS-SPME [19]
Heptadecene
Nonadecene
Eicosene
Heneicosene
Tetracosene
Decane Italy Fresh leavesHS-SPME [51]
Tridecane
Pentadecane
Heptadecane
Ketones 1-Penten-3-one Italy Fresh leavesHS-SPME [19]
Octan-2,5-dione
trans-β-Ionone
2-Heptanone Italy Dried rootsHS-SPME [51]
2-Nonanone
(E,E)-3,5-Octadien-2-one
1-Phenyl-1-propanone
Nitriles 4-Pentenenitrile Italy Fresh leavesHS-SPME [19]
3-Hydroxy-4-pentenenitrile
Heptanenitrile
Octanenitrile
2-Phenylacetonitrile
2-Pentenenitrile Italy Dried rootsHS-SPME [51]
Plants 2020, 9, 298 13 of 40
Table 1. Cont.
Chemical Class Compound Site ofCollection Plant Part/Extract Ref.
4-Pentenenitrile
2,4-Pentadiene nitrile
Fatty acids Palmitic acid Turkey
Seed
Chloroform-Methanol
(2:1 v/v)
[52]
Linoleic acid
Oleic acid
Linolenic acid
Stearic acid
11-Eicosenoic acid
Arachidic acid
Erucic acid
Behenic acid
15-Tetracosanoic acid
Tetracosanoic acid
Ursolic acid Germany Dried rosette leavesDichloromethane [33]
Palmitoleic acid
α-Lysolecithin
(7Z, 10Z, 13Z)-Hexadecatrienoic acid
Corchorifatty acid B
9-Hydroxy-(10E, 12E, 14E)-octadecatrienoic acid
9-oxo-(10E, 12Z, 15Z)-Octadecatrienoic acid
Polysaccharides Root [34]
4.1. Alkaloids
I. tinctoria is an important source of two known indolic alkaloids called indigo and indirubin.
The first one has a blue colour instead of the second one that has a red colour and both of them are
extensively used to dye textiles, cosmetics, foods, and pharmaceutical preparations. The plant is not
able to synthetize directly into the indigoid pigments, but it produces several precursors: indican,
isatan A, isatan B, and isatan C (Figure 2). When the leaves are damaged and exposed to air, precursors
are submitted to enzymatic hydrolysis by β-d-glucosidase and β-glucuronidase. After cleavage of
the O-glycosidic linkage, the indoxyl is released giving, in turn, indigo (blue indigoid pigments)
through the oxidation process, and producing isatin as a side reaction thanks to an oxygen-rich
environment. Eventually, the condensation of indoxyl with isatin produces indirubin (red indigoid
pigment), whereas the condensation with dioxindole, coming from Isatan C, produces isoindirubin
(red indigoid pigment) [44].
The indigo precursors indicant as well as isatans B and C were detected by Maugard et al. [44] in
the acetone/acetic acid 1% v/v extracts of I. tinctoria young and old fresh leaves. Moreover, the number
of indigo precursors in these samples was quantified by the same team, who established that isatan B
was the major precursor. The concentration of indigo precursors was higher in the young, fresh leaves
than in the oldest ones.
A later study of Oberthur et al. [53]. about I. tinctoria liophylized or air-dried leaves identified
isatan A as the major indoxyl glycoside and gave the correct structure of isatan B, which was previously
assigned by Epstein et al. [54]. Furthermore, the same team showed how the content of indigo
precursors strictly depended on the post-harvest treatments. A mix of I. tinctoria young and older
Plants 2020, 9, 298 14 of 40
rosette leaves were submitted to three different post–harvest treatments: immediate shock freezing
with liquid N2 followed by freeze drying, air drying at room temperature, and drying in a thermostatic
oven at 40 ◦C. The highest concentrations of isatans A and B were found in freeze dried leaf samples
whereas the indican had the lowest amount. On the other hand, the other two treatments lead to high
concentrations of indican and complete disappearance of isatans A and B. In all samples, the isatan B
concentrations were lower than those of isatan A. These data and the enzymatic conversion of indican
to isatan B underlined the biosynthetic pathway where isatan B derived from indican is, at the same
time, a biogenetic precursor and degradation product of isatan A. Eventually, the production and
amount of indigo precursors depend on the cultivars and harvest period, which also influenced the
indigo dyes’ composition [55].
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Figure 2. Chemical structure of indigo precursors.
In addition to the indigo precursors, indigoid pigments named trans-indigo (indigotin, blue),
trans-indirubin (isoindigotin, red), cis-indirubin (isoindirubin, red), iso-indigo (indigo brown), and
cis-indigo were detected by HPLC in the acetone/acetic acid 1% v/v extracts of I. tinctoria young and old
fresh leaves (Figure 3) [44]. It is also important to point out that the indigo dyes indigo and indirubin
appear under the fermentative conditions, used in the old natural indigo production, or after a drying
process at 40 ◦C [45].
Beyond the study of I. tinctoria fresh leaves, one unique analysis on dried rosette leaf extracts were
carried out by Mohn et al. [33]. Thanks to the extractions performed through two different solvents,
known as dichloromethane and methanol, it was possible to obtain a broad-based characterisation
of the I. tinctoria profile. The LC-MS analysis of dichloromethane extracts showed various indolic
alkaloids such as isatin, isoindigo, indoxyl indigo, and indirubin. Instead, in the methanolic extracts,
only indican was detected [33].
Recently, LC-MS analysis of I. tinctoria frozen and lyophilized and dried leaf extracts were
performed and the obtained metabolite profiles were compared. In the lyophilized extracts’ analysis,
beyond the characterization and quantification of 122 compounds previously described, the following
indole derivatives were described for the first time: acetylindican, malonylindican, two dioxindole
glucosides, dioxindole malonylglucoside (Isatan C), 6-hydroxyindole-3-carboxylic acid 6-O glucoside,
and 6-hydroxyindole-3-carboxylic acid glucose ester [45].
Several research studies carried out on I. tinctoria dried roots showed two new and five known
indole alkaloid glycosides. The structure of the two new indole alkaloid glycosides isatindigoside A and
isatindigoside B were determined by extensive spectroscopic data analysis including 1 D, 2 D NMR, IR,
Plants 2020, 9, 298 15 of 40
and HR-ESI-MS data analysis. The known glycosides isatindosulfonicacid A 3-O-b-d-glucopyranoside,
indole-3-acetonitrile 6-O-b-d-glucopyranoside, isatindigobisindoloside A, isatindigobisindoloside B,
and isatindigobisindoloside F, were identified by comparing spectroscopic and optical rotation data [37].
Furthermore, a new indole alkaloid with an unusual carbon skeleton named isatisindigoticanine A
were detected by the same team [56].
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Another important compound of this class is tryptanthrin, indolo-[2,1-b]-quinazoline alkaloid
(Figure 4), which is also responsible for some biological activities of I. tinctoria. Honda et al. [43]
isolated and identified tryptanthrin from I. tinctoria dried rosette leaf chloroform extracts for the first
time. Moreover, more than 70 Isatis samples of different origin were analysed and the tryptanthrin
content in the leaves varied from 0.56 to 16.74 × 10−3% [57]. The tryptanthrin synthetic pathway is
not known, but it is a product of the post-harvest process. Its formation is apparently favoured by
the drying process and elevated temperature (40 ◦C) and, on the contrary, the lyophilization and
fermentative conditions decreased its concentration [58].
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4.2. Phenolic Compounds
The main class of secondary metabolites in I. tinctoria polar extracts is represented by phenolic
compounds [16,47]. Phenolics can be divided into three main categories: flavonoids, phenolic acid, and
their conjugates [16]. The identified flavonoids represent the major class of the phenolic constituent
and are derivatives of flavones and of flavonols [46].
In methanolic extract from dried leaves, the presence of p-hydroxybenzoic, o-methoxybenzoic,
p-methoxybenzoic, dihydrocaffeic, and 4-hydroxy-3-methoxyphenylpropanoic acid has been
reported [48]. They found methyl esters of several phenolic acids, like ferulic, sinapic, salicylic,
vanillic, and 4-hydroxyphenylacetic acids as a result of acidic hydrolysis.
The same kind of extract was analysed by Mohn et al. [33]. In dried rosette leaves, they
found vicenin-2, stellarin-2, isoorientin, isovitexin, isoscoparin, and some of their glucosides
(Figure 5). Simultaneously, the isocoparin, sinapic, and ferulic acids turned out from the analysis of
dichloromethane extract from the same plant material.
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glucosides of isoscoparin, 4′-O-feruloyl iscoscoparin-3”-O-glucoside-7-O-glucoside, 2”-O-feruloyl
iscoscoparin-3”-O-glucoside-7-O-glucoside, and isoscoparin-3”-O-glucoside-7-O-feruloylglucoside.
In the same extract, the luteolin-6-C-glucoside-7-O-glucoside was detected for the first time and it has
not been described in other plants before.
Miceli et al. [46] characterised, for the first time, the phenolic compounds of the hydroalcoholic
extract (70% methanol) from I. tinctoria lyophilized cauline leaves. Among 13 identified flavonoids,
derivatives of flavones and flavonols, which were quantitatively dominant, were vicenin-2, isovitexin,
and apigenin glucosides. Some of them like kaempferol, buddleoside, and quercetin have not
been detected in Isatis before. Moreover, the authors reported the presence of phenolic acids like
neochlorogenic, chlorogenic, caffeic, ferulic, sinapic, p-coumaric, and coumarylquinic acids (Figure 6).
Neochlorogenic and sinapic acids were dominant compounds.Plants 2020, 9, x FOR PEER REVIEW 21 of 43 
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The same authors also performed a comparative analysis of hydroalcoholic extracts from rosette
leaves, cauline leaves, and flowers of I. tinctoria [47]. According to the results, the phenolic profile
of both types of leaves was very similar, but cauline leaves showed more than double the phenolic
content than rosette leaves. A lower number of phenolic compounds was detected in the flower
extract. Nonetheless, they were found to be quantitatively close to those of cauline leaves. The
main flavonoids detected in leaves and flowers from I. tinctoria were vicenin-2, stellarin-2, isovitexin,
luteolin-glucuronide, and quercetin. Among them, vicenin-2 turned out to be the most abundant
flavonoid detected in the cauline leaf extract, whereas luteolin-glucuronide and stellarin-2 were the
main compounds for rosette leaves and flowers, respectively [47].
4.3. Glucosinolates
I. tinctoria is a notable source of glucosinolates, which are synthesis and storage products of
isothiocyanates. When the plant tissue is damaged, glucosinolates are released and converted by
myrosinase (β-thioglucosidase). This is an enzyme that coexists with these compounds in plants
even though it is physically separated [19]. The enzyme hydrolyzes the glucose moiety into the main
skeleton by giving isothiocyanates and, under certain conditions, this reaction may lead to other
types of products like thiocyanates, indoles, epithionitriles, and nitriles [59]. These compounds are
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responsible for the bitter and pungent taste and for most of the biological activities of the glucosinolates
such as anticancer, antioxidant, and antibacterial factors.
Moreover, glucosinolates are known as goitrogens because they prevent the absorption of iodine,
which causes swelling of the thyroid.
From the chemical point of view, glucosinolates are (Z)-N-hydroxyminosulfate esters characterized
by sulphur-linked β-d-glucopyranose moiety and an amino acid-derived side chain. They are
divided into three groups according to their amino acid side chain: aliphatic glucosinolates, aromatic
glucosinolates, and indole glucosinolates [60].
In I. tinctoria seeds, aliphatic glucosinolates as gluconapin, progoitrin, and epipogoitrin, which
were mainly detected, but indolic glucosinolates like glucoisatisin/epiglucoisatisin (inseparable
epimeric mixture present only in seeds), glucobrassicin and neoglucobrassicin were also identified.
The glucosinolate pattern of the seeds extract showed differences when compared to the extract
obtained from the rosette leaves. In fact, the extracts obtained from I. tinctoria frozen and liophylized
rosette leaves, mainly contained indolic glucosinolates including glucobrassicin, neoglucobrassicin,
sulfoglucobrassicin, and glucotropaeolin (Figure 7) [49,50].
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The analysis carried out by the same authors also showed that the glucosinolate content in the
leaf samples was higher than that of the seed samples. Taviano et al. [47] showed that a very low
amount of glucoiberin, glucobrassicin, and 4-methoxyglucobrassicin are contained in the liophylized
leaf (rosette and cauline) and flower of 70% methanol extracts.
Furthermore, recent studies reported, for the first time, the presence of gluconapoleiferin in the
frozen and lyophilized rosette leaf methanol extracts [16].
4.4. Carotenoids
Carotenoids are highly lipophilic metabolites and, for this reason, the extraction and separation
conditions were optimized for the analysis. On one hand, the dichloromethane extract of I. tinctoria
dried rosette leaves showed several known carotenoids like (all-E)-β-carotene and various lutein
isomers [33]. On the other hand, in the hexane/acetone extract (1:1 v/v) obtained from the dried rosette
leaves, it was possible to detect more and other unknown carotenoids like (all-E)-lutein, (Z)-neochrome,
(15Z)-violaxanthin [33].
Moreover, in the same extract, the lipophilic chlorophyll degradation products phaeophytin a, b,
and pyrophaeophytin a, b were identified.
4.5. Monolignols and Oligolignols
Phenolic derived compounds with higher molecular weight belonging to monolignols and
oligolignols were described by Nguyen et al. [16]. In methanol extracts of I. tinctoria frozen and
lyophilized rosette leaves, monolignols and oligolignols, derived from coniferyl and synapyl alcohol,
were characterized by LC-MS for the first time. Some of these compounds were previously identified
in other plants such as Arabidopsis thaliana and Linum usitatissimum. Furthermore, several compounds
containing hexose, guaiacyl, and syringyl units linked by 8-5 and 8-O-4 bonds were detected for
the first time and all compounds were found in a hexosylated form. Authors underlined that they
were accumulated in the vacuole of mesophyll and epidermal cells rather than in the cell walls of
the leaf nervature. This finding suggested that oligolignols may play some physiological role in
I. tinctoria leaves.
4.6. Volatile Constituents
The volatile constituents of I. tinctoria were characterized in leaves and roots. The first extraction
from fresh leaves was carried out by Condurso et al. [19] through solid-phase microextraction and gas
chromatography-mass spectrometry (SPME/GC-MS). This analysis allowed them to identify several
compounds such as acids, alcohols, aldehydes, esters, ethers, furans, hydrocarbons, isothiocyanates,
thiocyanates, ketones, nitriles, sulfurated compounds, monoterpenoids, and sesquiterpenoids. A high
portion of volatile isothiocyanates was detected in the leaves (40% of the total volatile fraction), especially
3-butenyl isothiocyanate that is the aglicone of gluconapin. The 2-hydroxy-3-butenyl isothiocyanate,
that is, the aglicone of progoitrin and epiprogoitrin, was also identified. After the isothiocyanates,
aldehydes were the most represented class and both aliphatic and aromatic types were identified,
especially the (Z)-2-esenal (a typical aldehyde from leaves). Among the sulfurated compounds,
the 2-ethylthiophene was the most abundant one. Moreover, saturated and unsaturated alcohols
were identified with tetradecanol as the main component. Almost 7% of the volatile fraction was
represented by monoterpenoids and sesquiterpenoids. Ten monoterpenoids and two sesquiterpenoids
were detected and the monocyclic monoterpenoid limonene was the major one. Furthermore, the
nitriles that derive from isothiocyanates due to the loss of sulphur were detected, which were
4-pentenenitrile, 3-hydroxy-4-pentenenitrile, heptanenitrile, octanenitrile, and 2-phenylacetonitrile as
the most abundant ones.
Verzera et al. [51] carried out the first extraction of I. tinctoria dried root volatile constituents by
SPME/GC-MS and the same main classes of compounds were identified. The volatile content of roots
was also characterized by a high portion of 3-butenyl isothiocyanate that represents 82% of the total
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volatiles. After isothiocyanates, the alcohols and nitriles were the most abundant classes and they,
respectively, constituted 4.9% and 3.6% of the total volatile content. The other classes of compounds
are even less represented.
4.7. Other Constituents
Different studies have shown that polysaccharides from roots are important bioactive components
of I. tinctoria. In a study carried out by Han et al. [34], the conditions that gave the maximum extraction
yield of the polysaccharides from I. tinctoria root (11.19% ± 0.04) have been established. The seeds
of I. tinctoria, like those of other plants belonging to family Brassicaceae, show an interesting fatty
acid composition, which is the highest among all Isatis spp. (10%). According to Kizil et al. [52],
seeds contain erucic acid (26.48% of total fatty acid fraction), oleic, linoleic, linolenic acids as the
major components, and other fatty acids like palmitic, stearic, arachidic, and tetracosanoic. Moreover,
Mohn et al. [33] reported the presence of palmitoleic and α-lysolecithin in dichloromethane dried
rosette leaf extracts. Additionally, the presence of the triterpenoid ursolic acid was confirmed by
these authors.
The microelement analysis of the I. tinctoria seeds carried out by Kizil et al. [52] showed the presence
of K (3493 mg/kg), Ca (2173 mg/kg), P (625.6 mg/kg), Mg (593.0 mg/kg), Fe (77.54 mg/kg), Al (74.78 mg/kg),
Na (66.31 mg/kg), Mn (7.383 mg/kg), Ni (4.789 mg/kg), Pb (2.493 mg/kg), Cu (1.888 mg/kg),
Cr (0.630 mg/kg), and Cd (0.250 mg/kg).
5. Biological Activities
A number of studies have been conducted to evaluate different biological activities of I. tinctoria
in both in vitro and in vivo experimental models. Biological investigations are mainly based on the
ethnopharmacological uses of the plant as an effective anti-inflammatory, anti-tumour, and antiviral
herbal remedy. In addition, other biological activities such as analgesic, antimicrobial, and antioxidant
have been highlighted (Table 2).
Table 2. Biological activities of extracts and isolated compounds from I. tinctoria L.
Biological Activity Experimental Model Site ofCollection
Plant Part/
Extract or
Compound
Mode of
Administration
and Doses
Ref.
Anti-inflammatory
Activity
Chronic P. aeruginosa lung
infection mimicking cystic
fibrosis in rat
Pharmac.
factory of
Sichuan Yaan
Aqueous s.c.400 mg/kg [61]
Micro-dialysis assay in the
ex vivo pig foreleg skin Germany
Dried rosette leaf
Supercritical fluid
Tryptanthrin
topical
0.5 g/10 mL + Try
0.115–1.84 mg/mL
[62]
SLS-induced irritant contact
dermatitis and UVB-induced
erythema in healthy human
volunteers
Germany
Dried rosette leaf
Supercritical fluid
Tryptanthrin
topical
50 µL
50 µL
[63]
Carrageenan-induced paw
oedema in mouse Germany
Dried rosette leaf
Dichloromethane
Supercritical fluid
Tryptanthrin
per os
75–125 mg/kg
125–175 mg/kg
70–40 mg/kg
[18]
TPA-induced ear oedema in
mouse Germany
Dried rosette leaf
Dichloromethane
Supercritical fluid
Tryptanthrin
per os
125 mg/kg
100 mg/kg
70 mg/kg
[18]
Dried rosette leaf
Dichloromethane
Supercritical fluid
Tryptanthrin
topical
0.5 mg/ear
0.5 mg/ear
0.25 mg/ear
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Table 2. Cont.
Biological Activity Experimental Model Site ofCollection
Plant Part/
Extract or
Compound
Mode of
Administration
and Doses
Ref.
TPA-induced ear oedema in
mouse (sub-chronic
inflammation)
Germany Dried rosette leafDichloromethane
per os
150 mg/kg
topical
1 mg/ear
[18]
Delayed-type
hypersensitivity induced by
DNFB in mouse
Germany Dried rosette leafDichloromethane
per os
150 mg/kg
topical
1 mg/ear
[18]
Adjuvant-induced arthritis
in rats Germany Dried rosette leafDichloromethane
per os
150–250 mg/kg [64]
TNF-α and IL-1β production
in RAW 264.7 macrophages Germany
Dried rosette leaf
Dichloromethane 25–100 µg/mL [64]
OVA-induced allergic
airway disease (asthma) in
mouse
Dried leaf
Supercritical fluid
intranasal
10–100 µg/mouse [65]
Analgesic
Activity Writhing test in mice Germany
Dried rosette leaf
Dichloromethane
Tryptanthrin
per os
150–200 mg/kg
40 mg/kg
[18]
Anti-tumour
Activity
Clinical trials
(patients with chronic
myelocytic and chronic
granulocytic leukaemia)
Indirubin per os150–450 mg/day [66]
Human gastric cancer cells
(HGC)
Lung cancer cells (HLC)
Promyelocytic leukaemia
cells (HL-60)
Tryptanthrin
IC50 =
1.5 µg/mL
2.2 µg/mL
4.2 µg/mL
[67]
Human monocytic (U-937)
and promyelocytic (HL-60)
leukaemia cells
Tryptanthrin
0.78–25 µg/mL
IC50 =
3.1–6.3 µg/mL
[68]
Azoxymethane-induced
intestinal tumor in F344 rats Tryptanthrin
per os
50 mg/kg [69]
Mammary carcinoma cell
line (MCF-7) and
Large cell lung tumour
xenograft cell line
(LXFL529L)
Indirubin
IC50 =
4.0 ± 2.0 µM
9.9 ± 0.1 µM
[70]
MCF-7 cells
and Doxorubicin-resistant
breast cancer (MCF-7/adr)
cells
Tryptanthrin 10-6 M [71,72]
Myelomonocytic leukaemia
induced in BALB/c mice by
WEHI-3B JCS cells
Tryptanthrin
i.p.
0.04–0.16
mg/kg/day
[73]
Murine myeloid leukaemia
(WEHI-3B JCS) cells Tryptanthrin
0–5 µM
IC50 =
1.5 µM
[73]
Human chronic myeloid
leukaemia K562 cells Tryptanthrin
0.39–25 µg/mL
IC50 =
8.8 µg/mL
[74]
Xenograft human prostate
tumour in BALB/c nude
mouse model
Indirubin
Intralesionally
injected
10 mg/kg/day
[75]
Human umbilical vein
endothelial cell (HUVEC)
and Human prostate cancer
cells (PC-3)
Indirubin 0–100 µM [75]
Plants 2020, 9, 298 22 of 40
Table 2. Cont.
Biological Activity Experimental Model Site ofCollection
Plant Part/
Extract or
Compound
Mode of
Administration
and Doses
Ref.
N-myc amplified human
neuroblastoma LA-N-1 cells Tryptanthrin
0–30 µM
IC50 =
15.8 ± 1.41 µM
[76]
Matrigel plug assay
in BALB/c mice Tryptanthrin 0–20 µM [77]
Human microvascular
endothelial HMEC-1 cells Tryptanthrin 0–20 µM [77]
Non-small cell lung cancer
NCI-H460,
human glioblastoma SF-268,
and human breast cancer
MCF-7 cells
Tryptanthrin
IC50 =
8.5 ± 0.8 µM
22.6 ± 1.1 µM
9.4 ± 0.3 µM
[78]
Human anaplastic thyroid
cancer cell lines CAL-62 and
8505C cells
Italy
Frozen and
lyophilized
cauline leaf
Phenolic-rich
fraction
0.01–0.1 mg/mL [46]
Human anaplastic thyroid
cancer cell lines CAL-62,
8505C and C-643
Italy
Frozen and
lyophilized
Rosette leaf
Cauline leaf
Flower
70% Methanol
0.1–1 mg/mL [47]
DMBA/PMA-induced skin
carcinogenesis model in
Swiss albino mice
Tryptanthrin topical0.5–1 mg [79]
Antimicrobial
activity
Agar dilution test
for bacteria, yeasts, and
dermatophytes
Tryptanthrin 3.1–400 µg/mL [80]
Paper disc method for
phytopathogenic
microorganisms
Tryptanthrin 1–500 µg/mL [80]
Agar diffusion test
for 23 micro-organisms.
Sensitive strains: Bacillus
mycoides, B. subtilis,
tetracycline resistant
Micrococcus luteus, and
Saccharomyces cerevisiae
Germany Fresh whole plantWater/Ethanol - [81]
Agar dilution test
for synergistic activity with
antibiotics against
Methicillin-resistant (MRSA)
and standard Staphylococcus
aureus
China Dried leaf75% Ethanol 500 µg/mL [82]
Agar diffusion test
for 15 micro-organisms.
Sensitive strains:
Staphylococcus epidermis, S.
aureus, and MRSA
Tryptanthrin 12.5–100 µg/mL [83]
Microdilution broth method
for MRSA Tryptanthrin 15–1000 µg/mL [84]
Micro-titter plate method
for 14 micro-organisms.
Most sensitive strains:
B. subtilis, M. luteus and S.
aureus
Not indicated
Branches, flowers,
leaves and roots
Extracted with 14
different solvents
3.7–100 µg/mL
for bacterial strains [85]
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Table 2. Cont.
Biological Activity Experimental Model Site ofCollection
Plant Part/
Extract or
Compound
Mode of
Administration and
Doses
Ref.
Antiviral
activity
Production of RANTES by
Human bronchial epithelial
cells H292 infected with
influenza virus A/NWS/33
and B/Lee/40 – ELISA
Indirubin 100–200 µM [86]
Human influenza viruses
(H1N1 and H3N2) and avian
influenza viruses (H6N2 and
H9N2) – MTT assay
Polysaccharides
IC50 =
from 4.35 ± 0.07 to
28.20 ± 0.49 mg/mL
[87]
Vero cells infected with
Herpes simplex virus type II
(HSV-2) - Cytopathic effect
and MTT assay
Polysaccharides 25–800 mg/L [88]
Antioxidant
activity
1,1-diphenyl-2-picrylhydrazyl
(DPPH) test
Leaf
Hydroalcoholic
SC50 =
103.9 µg/mL [89]
2,2-Azino-bis-3-ethylbenzothiazoline—6-sulfonic
Acid (ABTS) assay Polysaccharides
Scavenging effect
at 0.3 mg/mL= 64.3% [34]
1,1-diphenyl-2-picrylhydrazyl
(DPPH) test
Dried I. tinctoria
(plant part not
specified)
95% Ethanol
IC50 =
1583.45 ± 23.69
mg/mL
[90]
Trolox Equivalent
Antioxidant Capacity
(TEAC)
mM Trolox/g =
589 ± 0.51 [90]
Reducing power assay Abs700 =0.32 ± 0.004 [90]
1,1-diphenyl-2-picrylhydrazyl
(DPPH) test
Indigo
Indirubin
EC50 =
> 0.26 mg/mL
> 0.26 mg/mL
[91]
Superoxide anion radical
scavenging activity
Indigo
Indirubin
EC50 =
0.61 mg/mL
0.74 mg/mL
[91]
Hydroxyl radical
scavenging activity
Indigo
Indirubin
Not active
Not active [91]
Reducing power IndigoIndirubin
Not active
Not active [91]
1,1-diphenyl-2-picrylhydrazyl
(DPPH) test Italy
Frozen and
lyophilized
cauline leaf
Phenolic-rich
fraction
IC50 =
0.6657 ± 0.0024
mg/mL
[46]
Reducing power Italy
Frozen and
lyophilized
cauline leaf
Phenolic-rich
fraction
ASE/mL =
3.87 ± 0.71 [46]
Ferrous ions (Fe2+) chelating
activities assay
Italy
Frozen and
lyophilized
cauline leaf
Phenolic-rich
fraction
Not active [46]
Protective effect on
Escherichia coli under H2O2
stress
Italy
Frozen and
lyophilized
cauline leaf
Phenolic-rich
fraction
Not active [46]
Plants 2020, 9, 298 24 of 40
Table 2. Cont.
Biological Activity Experimental Model Site ofCollection
Plant Part/
Extract or
Compound
Mode of
Administration and
Doses
Ref.
1,1-diphenyl-2-picrylhydrazyl
(DPPH) test Italy
Frozen and
lyophilized
Rosette leaf
Cauline leaf
Flower
70% Methanol
IC50 =
1.151 ± 0.004 mg/mL
0.581 ± 0.001 mg/mL
0.437 ± 0.003 mg/mL
[47]
Reducing power Italy
Frozen and
lyophilized
Rosette leaf
Cauline leaf
Flower
70% Methanol
ASE/mL =
2.775 ± 0.163
1.546 ± 0.006
2.799 ± 0.042
[47]
Ferrous ions (Fe2+) chelating
activities assay
Italy
Frozen and
lyophilized
Rosette leaf
Cauline leaf
Flower
70% Methanol
IC50 =
1.234 ± 0.010 mg/mL
0.564 ± 0.011 mg/mL
0.856 ± 0.002 mg/mL
[47]
5.1. Anti-Inflammatory Activity
I. tinctoria has been appreciated for centuries in Europe and, in TCM, for its anti-inflammatory
properties. For this reason, several in vivo and in vitro research studies were carried out in order to
assess its anti-inflammatory potential.
Solvents with different polarity and diverse extraction procedures (maceration, reflux extraction,
CO2 supercritical fluid extraction (SFE), and accelerated solvent extraction (ASE)) were utilized in
order to establish the best condition to extract the bioactive compounds contained in the leaves and
roots of I. tinctoria.
One of the earliest studies investigated the effects of the treatment with an aqueous extract of
I. tinctoria in a model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis in rat.
I. tinctoria (400 mg/kg b.w., s.c. once a day for 10 days) was able to decrease the frequency of the lung
abscess and the severity of the macroscopic pathological changes in lungs. The I. tinctoria extract was
also able to modulate and decrease the inflammatory response in the lungs by enhancing the shift
in the inflammatory response from an acute type inflammation dominated by polymorphonuclear
leukocytes to a chronic type inflammation dominated by mononuclear leukocytes [61].
The anti-inflammatory activity of lipophilic I. tinctoria leaf extracts was demonstrated.
Recio et al. [18] showed the efficacy of SFE and dichloromethane (DCM) extracts obtained from
dried rosette leaves of I. tinctoria, using two experimental models of acute inflammation including
carrageenan-induced mouse paw oedema and 12-O-Tetradecanoylphorbol 13-acetate (TPA)-induced
mouse ear oedema. The SFE (os, 75–125 mg/kg) and DCM (os, 125–175 mg/kg) extracts
showed dose-dependent anti-inflammatory activity in the carrageenan-induced mouse paw oedema.
Particularly, the potency of the SFE extract was found higher than that of DCM. In the second in vivo
model of acute inflammation, the topical application of the DCM and SFE extracts (0.5 mg/ear)
significantly inhibited the TPA-induced ear oedema and the topical administration was more effective
than the systemic one.
In sub-chronic inflammation induced by repeated application of TPA in the mouse ear, both
oral (150 mg/kg) and topical (1 mg/kg) administration of DCM extract inhibited oedema formation
and reduced the neutrophil infiltration, which decreased the various parameters of the inflammatory
response such as the hypertrophy of fibroblasts, papillomatosis, acanthosis, hyperkeratosis, and
spongiosis [18]. The anti-inflammatory properties of these extracts have been explained with
multi-faceted effects including, among others, a marked COX inhibitory activity, with a preferential
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inhibition of COX-2, inhibition of 5-LOX, iNOS, histamine and serotonine release, and leukocytic
elastase, as previously demonstrated by Danz et al. [17,92].
In a model of delayed-type hypersensitivity (DHT) induced by dinitrofluorobenzene (DNFB) in
mice, the lipophilic DCM extract, topically administered (1 mg/ear), inhibited the response both during
the induction phase and the inflammatory phase. Instead, the oral administration had no effect [18].
Adjuvant-induced arthritis in rats is an experimental in vivo model mimicking the rheumatoid
arthritis and it was utilized with the aim to evaluate the effect of a DCM extract on chronic inflammatory
diseases [64]. In this model, the DMC extract (os, 150 mg/mL once/day, on days 17–23 by injection of the
adjuvant) led to a significant reduction of paw oedema induced by injection of Mycobacterium butyricum.
This effect did not result in a dose-dependency. A decreased joint damage, a reduction of tissular and
articular inflammatory markers (oedema, cell infiltration, articular damage, pannus, cysts etc.), bone,
and cartilage erosion was observed. Interestingly, the treatment over two weeks with a high dose
of I. tinctoria extract did not determine macroscopic lesions of the rat gastric mucosa. The treatment
did not cause a significant difference in tissue levels of COX-1 and COX-2, immunohistochemically
determined. These results appear to disagree with those reported by Orberthür et al. [29] where a
preferential inhibition of COX-2 and a reduced expression of iNOS was observed. In vitro studies
demonstrated that the DCM extract is able to inhibit both tumour necrosis factor-α (TNF-α) and IL-β
production in RAW 264,7 macrophages [64]. Thus, the anti-inflammatory and anti-allergic activity of I.
tinctoria DCM extract highlighted in the arthritis and DTH models was related to the reduction of the
production of these cytokines.
Brattström et al. [65] demonstrated the anti-inflammatory effects of SFE extract from the I.
tinctoria leaves in a murine experimental model of allergic airway disease (asthma). The extract,
administered intranasally (10–100 µg/mouse) to ovalbumin immunised BALB/c mice, determined a
dose-dependent inhibition of the allergic reaction, which decreases the methacholine-induced airway
hyperresponsiveness (AHR) and eosinophil recruitment, as determined both in the bronchoalveolar
lavage (BAL) fluid and in the lung homogenates. The observed effect was related to the reduced
production of the typical mediators of the Th2 immune response IL-4, IL-5, and RANTES (Regulated on
Activation Normal T cell Expressed and Secreted) highlighted after treatment with I. tinctoria extract.
The anti-inflammatory activity of I. tinctoria was also evaluated in a clinical pilot study. The efficacy
of the topical administration of different lipophilic extracts of I. tinctoria leaves was confirmed on
healthy human volunteers using two experimental models, called sodium lauryl sulfate-induced irritant
contact dermatitis and UVB-induced erythema. I. tinctoria extracts are effective when administered
during the induction phase of dermatitis whereas they did not show any anti-inflammatory activity in
the UVB-induced erythema model [63].
Various lipophilic constituents belonging to different chemical classes play an important role
in the anti-inflammatory activity of I. tinctoria extracts such as the alkaloidis tryptanthrin, indirubin,
indolinone, and fatty acids as linolenic acid.
Tryptanthrin possesses a unique pharmacological profile. It has been shown to be highly
selective toward the COX-2 isoenzyme [17,92]. Nonetheless, other studies reported tryptanthrin as a
non-selective COX inhibitor [93]. It inhibited 5-lipooxygenase (5-LOX) catalysed leukotriene synthesis
in vitro and in vivo [18,92,94], and iNOS catalysed nitric oxide (NO) production [93]. In particular,
tryptanthrin was found to be a potent natural inhibitor of cellular leukotriene biosynthesis in human
whole blood and it is effective in vivo after oral administration in several experimental models such as
in a murine model of inflammatory bowel disease (100 mg/kg p.o. for 3 days), in carrageenan-induced
paw oedema in mice (50 mg/k p.o.), and in the rat pleurisy model (10 mg/kg p.o.) [18,94,95]. On the
contrary, this compound, when topically administered, showed no significant anti-inflammatory effect
in an animal model (TPA-induced ear oedema) [18] as well as in a clinical pilot study. In this study,
carried out on healthy human volunteers, tryptanthrin, topically administered, did not manifest any
protective effect both in the UVB-induced erythema model and in sodium lauryl sulfate-induced
dermatitis [63]. Thus, the pure compound is not effective when administered by topical application.
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This observation was also confirmed by Oberthür et al. [62] through an experimental model of cutaneous
micro-dialysis. It has been shown that the tryptanthrin contained in the extracts penetrates to a greater
extent than that of pure solutions. This is because, in the first case, the alkaloid remains in molecular
dispersion while, in the second case, it tends to crystallize on the surface of the skin.
One of the active compounds isolated from I. tinctoria leaves responsible for the anti-allergic
properties is the alkaloid indolin-2-one. It has been demonstrated that indolinone inhibits compound
48/80-induced histamine release from rat peritoneal mast cells [96]. Moreover, indolinone was found
to block IgE-mediated degranulation of sensitized mast cells at nM concentrations without directly
interfering with signalling upstream of the histamine-containing granules [97].
Several studies demonstrated that indirubin is a potent inhibitor of cyclin-dependent kinase 5
(CDK5/P25) and glycogen synthase kinase-3-β (GSK-3-β) [98] as well as interferon-γ and interleukin
(IL)-6 [99]. In the experimental model of LPS-induced pulmonary oedema in mice indirubin was
shown to diminish oxidative stress and inflammation by reducing MDA production as well as IL-1β
and TNF-α expression [100].
The analgesic potential of the lipophilic extract of I. tinctoria dried rosette leaves (DCM extract)
was shown in vivo by an acetic acid–induced abdominal writhing test. The oral administration of the
extract (200 mg/kg), before the intraperitoneal injection of acetic acid, reduced the number of writhing
and stretching movements in mice while tryptanthrin (40 mg/kg) had no such effect [18].
5.2. Anti-Tumor Activity
I. tinctoria has been used in China to treat patients with solid tumours and leukaemia [9]. Phase
I/II clinical trials highlighted very encouraging therapeutic effects of I. tinctoria in treating chronic
myelocytic leukaemia [101].
Experimental studies with transplantable tumours demonstrated that I. tinctoria significantly
prolonged the life span of Walker carcinosarcoma 256 bearing rats [101].
The anti-cancer properties of this species have been mainly attributed to the alkaloids’ indirubin
and tryptanthrin, whose activity has been demonstrated by in vivo and in vitro experimental models.
Numerous studies showed the potential efficacy of these compounds against a broad range of tumour
types and the mechanisms of action underlying their activity have been elucidated.
The bisindole indirubin has been described about 40 years ago as being active in treating human
chronic myelocytic leukaemia. Several trials published in China indicated that indirubin orally
administered at the dose of 150–200 mg of per day led to remission in 60% of patients [9]. It was
reported to induce complete remission in 26% and partial remission in 33% of 314 patients suffering
from chronic myelocytic and chronic granulocytic leukaemia, which exhibited low toxicity and had
limited adverse effects [66].
In animal leukaemia and lung carcinoma models, indirubin showed a good inhibitory effect and
low toxicity [6]. It was found to inhibit DNA synthesis in rats bearing Walker-256 sarcoma [102].
A weak binding of indirubin to DNA has been demonstrated in vitro by Wu et al. [103] using the
isotope labelling method, the spectrophotometric method, and thermal denaturation measurements,
which shows that the binding between indirubin and DNA might be of a hydrogen bond rather
than ionic.
In an experimental study carried out by Zhang and colleagues [75], the treatment for 25 days
with indirubin (10 mg/kg per day) has proven to be effective in inhibiting prostate tumour growth
in a xenograft mouse model (BALB/c nude mice) by inhibiting tumour angiogenesis, as confirmed
through a chick chorioallantois membrane (CAM) assay and a mouse corneal model (C57BL/6 mice).
Western blot analysis highlighted that indirubin suppressed endothelial cell viability by blocking a
vascular endothelial growth factor receptor 2- (VEGFR2) mediated Janus kinase (JAK)/STAT3 signalling
pathway in endothelial cells. In particular, the phosphorylation and activation of JAK2 and STAT3
was suppressed, and the STAT3 downstream genes including Bcl-2, Bcl-xl, Cyclin D1, Cyclin A, and
Survivin were down-regulated. The same authors also showed that indirubin effectively inhibited
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proliferation and induced apoptosis in human umbilical vein endothelial cells (HUVEC), while also
inhibiting migration and capillary-structure formation. The core proteins involved in apoptosis
including Caspase-3 and PARP were found to be activated.
The anti-tumour properties of indirubin and its derivatives appear to correlate with their antimitotic
potential and inhibition of cyclin-dependent kinases (CDKs) and cell cycle regulatory molecules, which
play an essential role in the regulation of cell proliferation, transcription, and apoptosis [70,104].
It was found that indirubin and its analogues inhibited the proliferation of the human large cell lung
carcinoma LXFL529L and human mammary carcinoma MCF-7 cells. The more soluble analogue
indirubin-3′-monoxime induced G2/M arrest in MCF-7 cells synchronized in the G2/M phase by
a transient exposure to nocodazole and this effect was mediated by the inhibition of CDK1 and
CDK1/cyclin B activity. This was suggested as a major mechanism by which indirubin derivatives
exert their potent anti-tumour efficacy [70].
Indirubins are also efficient inhibitors of CDK2 and CDK5/p35. They act by competing with
ATP for binding to the catalytic subunit of the kinase [102,105]. The crystal structure of the complex
CDK2/indirubin derivatives showed that indirubin interacts with the kinase’s ATP-binding site through
van der Waals interactions and three hydrogen bonds [102].
Another study published by Damiens et al. [106] reported that, after transient treatment with
indirubin-3’-monoxime of human breast epithelial HBL-100 cells synchronized in G2/M by nocodazole,
cells underwent an endoreplication. After the compound has been removed, the polyploid cells became
aneuploid and, later, died from necrosis. This mechanism of endoreplication followed by cell death
may contribute to the anti-tumour properties of indirubins.
The indole quinazolinone alkaloid tryptanthrin showed cancer chemo-preventive efficacy in
intestinal tumour formation induced by azoxymethane in F344 rats [69]. It was found to be able to
inhibit the growth of the murine myeloid leukaemia WEHI-3B JCS cells in the tumour-bearing BALB/c
mice [73].
Recently, tryptanthrin has also been shown to be an effective suppressor of non-melanoma skin
cancer (NMSC), as demonstrated by using dimethylbenz[a]anthracene/phorbol 12myristate 13acetate
(DMBA/PMA) induced skin carcinogenesis model in Swiss albino mice [79]. It was found that the
compound disrupted DMBA/PMA-induced expansion of hair follicle cells by suppressing the activation
of β-catenin, which is a major driver of hair follicle cell proliferation. Additionally, tryptanthrin
suppressed the activation of ERK1/2 and p38, in which both promote β-catenin activation and lowers
the expression of c-Myc and cyclin-D1. These are the transcriptional targets of β-catenin, which are
widely implicated in carcinogenesis.
Increasing evidence demonstrated that tryptanthrin is highly cytotoxic to a variety of a solid tumour
and leukaemia cell lines and has a broad range of downstream targets that regulate tumour-associated
cell processes including cell growth, cell cycle progression, and survival.
Tryptanthrin was found to inhibit the growth of human gastric cancer (HGC), lung cancer (HLC),
and promyelocytic leukemia HL-60 cells with IC50 values of 1.5–4.2 µg/mL [67]. It showed significant
cytotoxicity against non-small cell lung cancer NCI-H460, human glioblastoma SF-268, and human
breast cancer MCF-7 cell lines with IC50 values of 8.5–22.6 µM [78]. Tryptanthrin also exhibited a
multi-drug resistance reversing effect in doxorubicin-resistant breast cancer MCF-7 cells (MCF-7/adr),
which is higher than that of the multi-drug resistance (MDR)-reversing agent Verapamil through
down-regulation of MDR1 gene expression, and partly by modulating the GSTpi-related pathway,
which is a non-transporter pathway [71,72].
Liao and Leung [76] reported that tryptanthrin is able to inhibit the growth of the N-myc amplified
human neuroblastoma LA-N-1 cells (IC50 = 15.8 ± 1.41 µM) as well as two other human neuroblastoma
cell lines SH-SY5Y and SK-N-DZ, which induced cell cycle arrest at the G0/G1 phase. Western blot
analysis showed a marked down-regulation of Cyclin D1, Cyclin D3, CDK4, and CDK6, which are
known to be associated with the cell-cycle progression from the G1 to the S phase. LA-N-1 cells treated
with tryptanthrin underwent marked morphologic differentiation, enhancement of acetylcholine
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esterase activity, and up-regulation of various differentiation markers including growth-associated
protein 43 (GAP43), microtubule-associated protein tau (MAPT), calcitonin gene related peptide (CGRP),
and somatostatin, with an effect superimposable to that of 5 µM 9-cis-RA used as a positive control.
Moreover, tryptanthrin treatment led to a significant reduction of the N-myc proto-oncogene expression.
The anti-angiogenic activity has been proposed as an important mechanism underlying the
anti-cancer properties of tryptanthrin against various solid tumours. A study published by Liao
and colleagues [77] demonstrated that tryptanthrin inhibited angiogenesis both in vitro and in vivo.
In particular, it inhibited the proliferation of human microvascular endothelial HMEC-1 cells and
interrupted the migration and capillary-like structure formation. The anti-angiogenic effect was
confirmed in vivo by a Matrigel plug assay. The underlying molecular mechanisms of action
were explained by a reduced expression of pro-angiogenic factors such as Ang-1, PDGFB, and
MMP2, suppression of the phosphorylation of VEGFR2, and blockade of the VEGFR2-mediated
ERK1/2 signalling pathway. Molecular docking studies indicated that tryptanthrin could bind to the
ATP-binding site of VEGFR2.
Concerning the antileukemic activity, at low concentrations (0.5 µg/mL), tryptanthrin was found
to be able to enhance the expression of cell differentiation markers in human monocytic U-937 and
promyelocytic HL-60 leukaemia cells, which is indicative of their differentiation into monocytes and
macrophages. Higher concentrations inhibited cell proliferation and induced cell death by apoptosis in
the cultures by damaging the mitochondria that induces the apoptotic cascade through a caspase-3/Fas
antigen pathway [68].
Chan et al. [73] reported the potent anti-proliferative efficacy of tryptanthrin against murine
myeloid leukaemia WEHI-3B JCS cells, with an IC50 value of 1.5 µM at 48 h of treatment. Flow
cytometric analysis showed the cell cycle arrest of the cells at the G0/G1 phase in a dose-dependent
manner. The expression of the cell cycle-related genes including cyclin D2, D3, Cdk 2, 4, 6 was found
to be significantly down-regulated at 24 h as measured by real time PCR, which led us to propose the
prevention of the cell cycle progression from the G1-phase into the S-phase. This causes cell cycle arrest
as one of the mechanisms for leukemic cell growth inhibition. Furthermore, it has been suggested
that tryptanthrin exerts its anti-tumor effect on WEHI-3B JCS cells by triggering cell differentiation, as
demonstrated by morphological and functional studies.
Miao et al. [74] had proved that tryptanthrin significantly inhibited human chronic myeloid
leukaemia K562 cell proliferation with an IC50 value of 8.8 µg/mL after 48 h of treatment. Cell cycle
distribution analysis showed that it inhibited proliferation by blocking the cell cycle progression at
the G0/G1 phase and, subsequently, progressing into apoptosis. The underlying mechanism has been
attributed to the damage of mitochondrial membrane and the cyt-c-caspase-3 dependent mechanisms.
Besides the lipophilic compounds indirubin and tryptanthrin, the polar phenolic constituents have
also been shown to contribute to the anti-cancer properties of I. tinctoria. Recently, the anti-proliferative
properties of polar extracts obtained from I. tinctoria rosette leaves together with those from the
cauline leaves and the flowers have been evaluated [47]. To achieve the separation of the polar
compounds from the lipophilic ones, frozen and lyophilized plant material was sequentially extracted
with dichloromethane and 70% methanol. I. tinctoria polar extracts showed anti-proliferative effects
against the human anaplastic thyroid cancer ATC cell lines CAL-62, 8505C and C-643. Particularly, after
48 h of treatment, the basal leaf extract markedly inhibited the growth of CAL-62 cells, which caused
nearly 85% reduction of viability at the highest tested dose (1 mg/mL). The significant anti-proliferative
effects against ATC cell lines have been related to the flavonoids and the phenolic acids contained
in the extracts, characterized by HPLC-PDA/ESI-MS. Another study published by the same authors
confirmed that phenolics were mainly responsible for the observed activity. The anti-proliferative
properties of the phenolic-rich fraction obtained from I. tinctoria cauline leaf polar extract has been
demonstrated, which caused 80% and 65% growth inhibition in CAL-62 and 8505C cells, respectively,
after 48 h of exposure at the maximum tested dose (0.1 mg/mL). The activity of the phenolic-rich
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fraction against these cell lines was similar to that of Sunitinib used as a positive control, when tested
at the dose of 10 µM for 72 h [46].
5.3. Antimicrobial and Antiviral Activities
A few research studies investigated I. tinctoria as a potential source of valuable compounds
with anti-microbial efficacy against bacterial and fungal species. More thorough studies have been
conducted on components with antiviral activity, which have led to the identification of possible
mechanisms of action (Table 2).
The results of a study carried out by Dornberger and Lich [81] on the anti-microbial activity of
a hydroalcoholic (water/ethanol) extract of the fresh whole plant evaluated by an agar diffusion test
indicated that, among the 23 tested strains (Gram-positive, Gram-negative, yeast, and fungi), only the
Gram-positive tetracycline-resistant Bacillus mycoides SG 756 TF, B. subtilis ATCC 6633, and Micrococcus
luteus SG 125 A, and the yeast Saccharomyces cerevisiae JH 3 showed weak sensitivity to the extract.
By contrast, Ullah and colleagues [85] recently reported the good anti-microbial properties of different
extracts from I. tinctoria. In particular, the study concerned the evaluation of anti-microbial activity of
fractions obtained from different parts of the plant (branches, flowers, leaves, and roots) by extraction
with 14 different solvents, which was performed using a micro-titer plate method against seven
bacterial and four fungal strains. The obtained results showed that the extracts displayed antibacterial
activity, more elevated against Gram-positive strains (B. subtilis, M. luteus and Staphylococcus aureus).
In many cases, it was higher than the antibiotic cefotaxime used as a positive control as well as
antifungal activity (except for branches). In general, the leaves were found to be the best plant part
and ethyl acetate, n-hexane, chloroform, and acetone as the most efficient solvents for the extraction of
antimicrobial compounds.
The possible utilization of I. tinctoria in combination therapy with commonly used antibiotics for
treating infections caused by meticillin-resistant S. aureus (MRSA), which is a widespread cause of
both community-acquired and hospital-acquired infections associated with significant mortality and
morbidity, has been suggested. The dried leaf hydroalcoholic (75% ethanol) extract of I. tinctoria was
found to be able to potentiate the effects of four antibiotics (penicillin G, gentamicin, ciprofloxacin, and
ceftriaxone) against both MRSA (isolated from hospital patients) and standard (ATCC25923) S. aureus
strains [82].
Among the phytochemicals contained in I. tinctoria, the alkaloid tryptanthrin has been proven
to have an antimicrobial effect. Nonetheless, there are discrepancies between the results of various
research studies. One of the earliest published works is that of Honda and colleagues, who evaluated
the activity of tryptanthrin against a wide variety of microorganisms including bacteria, yeasts,
dermatophytes by the agar dilution streak method, and phytopathogens by the paper disc method.
The results of these investigations demonstrated that it displays strong activity against Bacillus subtilis
(MIC: 25 µg/mL) and B. polymyxa (MIC: 50 µg/mL), and it is a highly specific antimicrobial agent against
dermatophytes, which are causative of athlete’s foot, namely Trichophyton mentagrophytes, T. rubrum
IFO 5808, T. tonsurans var. sulfureum IFO 5945, Microsporum canis IFO 9182, M. gypseum IFO 8307,
and Epidermophyton floccosum IFO 9045 (MICs: 3.1–6.3 µg/mL) [43,80]. By contrast, the results of the
agar diffusion assay carried out by Chiang et al. [83] revealed that tryptanthrin showed no effect on
tested fungi including the dermatophytic pathogens E. floccosum ATCC 18397, M. gypseum ATCC 14683,
and T. rubrum ATCC 10218. The same authors reported that tryptanthrin significantly (≥12.5 µg/disc)
inhibited the growth of S. epidermis ATCC 12228 and S. aureus ATCC 6538, and only weakly suppressed
MRSA ATCC 43300 even at 100 µg/disc. This last result is in disagreement with that of a more recent
study, which highlighted a promising anti-bacterial activity of tryptanthrin against MRSA, as evaluated
by the agar diffusion method (MIC 62.5 µg/mL) [84].
The traditional Chinese medicine Bǎn Lán Gēn (Isatidis radix) is widely employed in the prevention
and treatment of a wide range of viral infections including seasonal flu, the deadly Severe Acute
Respiratory Syndrome (SARS), viral pneumonia, mumps, pharyngitis, and hepatitis [87,107]. Different
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types of compounds effective against influenza viruses have been isolated from I. radix. Indirubin
has been shown to have powerful activity vs. the influenza virus A/NWS/33- and B/Lee/40-infected
bronchial epithelial cells H292 by reducing both the expression and production of the chemokine
RANTES [86].
The polysaccharide compounds contained in I. radix also have anti-influenza virus activity,
as demonstrated by in vitro investigations. It has been reported that a polysaccharide isolated from
I. radix inhibited the attachment of the influenza virus to the red blood cells, which promoted the
generation of anti-influenza viral IgG antibodies [88]. In a study carried out by Li et al. [87], I. radix
polysaccharides showed potent anti-influenza A virus activity against human seasonal influenza
viruses (H1N1 and H3N2) and avian influenza viruses (H6N2 and H9N2). They were found to
effectively inhibit the expression of pro-inflammatory cytokines (IL-6) and chemokines (IP-10, MIG,
and CCL-5) induced by the human influenza virus PR8/H1N1 and the avian influenza virus H9N2.
Furthermore, the polysaccharides reduced the expression of the Toll-like receptor (TLR)-3 induced by
the PR8/H1N1 virus. These results led to hypothesize that the underlying mechanism of action of the
polysaccharides is to impair the upregulated expression of pro-inflammatory cytokines/chemokines
induced by the influenza virus by inhibiting the expression of host TLR-3.
The in vitro antiviral efficacy of the I. radix polysaccharide against type II herpes simplex
virus (HSV-2) has been recently demonstrated [88]. Using the 3-(4,5-dimethylthiazole-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay, this effect was shown to occur mainly by inhibiting the
viral duplication and adsorption.
5.4. Antioxidant Activity
In the last decade, some research has focused on the study of I. tinctoria as a source of natural
antioxidants. The first published articles concerning the antioxidant properties of I. tinctoria extracts
were those of Fialova et al. and of Yang et al. [89,90]. In the first work carried out on a hydroalcoholic
extract of the leaves, good radical scavenging activity in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) test
was found (SC50 = 103.9 µg/mL) whereas the second one reported very weak activity in the same test
as well as in the Trolox Equivalent Antioxidant Capacity (TEAC) and in reducing power assays for an
ethanol extract obtained from dried Chinese I. tinctoria.
The results of subsequent investigations on I. tinctoria leaves indicated that phytochemicals
belonging to different chemical classes act as antioxidants, such as alkaloids and phenolic compounds.
In a study carried out by Zhao and collegues [91], the antioxidant properties of the indole alkaloids
indigo and indirubin were evaluated by means of different in vitro assays. Indigo and indirubin were
found to be more effective for superoxide anion scavenging (EC50 = 0.61 mg/mL and 0.74 mg/mL,
respectively). This effect has been attributed to the presence of some electrophilic groups, such as keto
or aldehyde, which facilitate the release of hydrogen from the O–H bond and stabilize the superoxide
anion. Both compounds exhibited scavenging activities on a DPPH-free radical, whereas they did not
show hydroxyl radical (OH•) scavenging activity and reducing power.
It is well known that polyphenols represent the main class of natural antioxidants, which act in
different ways such as radical scavengers because phenolic groups are excellent nucleophiles and are
also able to inhibit lipid peroxidation, as breakers of the oxidation reaction by binding with free radicals
generated through lipid peroxidation, and as chelators of metal ions that induce oxidation [108]. Aimed
at establishing the involvement of phenolic compounds in the antioxidant properties of I. tinctoria,
recently, the polar extract obtained from the rosette leaves and also those from the cauline leaves and
the flowers have been investigated by in vitro assays based on different mechanisms [47]. Lyophilized
plant material was sequentially extracted with dichloromethane and 70% methanol in order to separate
the polar compounds from the lipophilic ones. The polar extracts were found to possess good radical
scavenging (DPPH test) and ferrous ions’ chelating activities and moderate reducing power, and those
from cauline leaves and flowers displayed better antioxidant efficacy than the rosette leaf extract. The
calculated coefficient of determination (R2) indicated that flavonoids were the phenolic compounds
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mainly involved in the observed antioxidant properties. Another study carried out by the same
authors on the phenolic-rich fraction obtained from I. tinctoria cauline leaf polar extract confirmed that
phenolics were mainly responsible for the good radical scavenging properties [46]. In particular, the
activity has been mainly related to the flavonols detected in the fraction, which have all the essential
structural elements for potent radical scavenging activity. Compared to flavone compounds, the
flavonols contain more hydroxyl groups (one to six) among which the OH group at the C-3 position has
a very high ability to scavenge the DPPH radical, such as quercetin and rutin, which are well-known
potent antioxidants. Interestingly, these works have highlighted the antioxidant activity not only of
the rosette leaves, which are commonly utilized for their medicinal properties, but also of the cauline
leaves and the flowers, which indicates a broader range of usage possibilities for this relevant species.
Even the roots of I. tinctoria are a source of antioxidant compounds. Indeed, the polysaccharides
contained in the roots were found to possess antioxidant properties in vitro. In particular, in a study
conducted by Han et al. [34], the polysaccharides extracted from the dried roots exhibited an appreciable
radical scavenging activity in the 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) assay,
reaching, at the maximum tested concentration (0.3 mg/mL), a percentage of inhibition (64.3%) close to
that of vitamin C used as a reference compound.
6. Plant Biotechnological Studies on I. tinctoria
It has been reported that the phytochemical profile of I. tinctoria field-cultivated is highly affected by
various factors including cultivar, geographical regions, climatic fluctuations, and soil conditions [109].
The techniques concerning plant in vitro cultures and the possibilities of increasing the
accumulation of secondary metabolites established by plant biotechnology are a known, alternative
source of many valuable biologically active secondary metabolites used in medicine as well as in
cosmetology and the food industry [110,111]. The many strategies used in plant biotechnology aimed
at increasing the in vitro culture biomass and/or bioactive metabolites’ production. The elaboration of
micropropagation protocols creates the possibilities of increasing and facilitating the specific, often
very demanding, plant multiplication [112]. For increasing the secondary metabolites production in
in vitro cultured biomass, different, specific strategies have been introduced [113]. The most important
ones are: the selection of high productivity cell lines, elaboration of the optimal culture conditions
(e.g., selection of basic formulation of the culture medium, type of plant growth regulators, and their
concentrations in the media, types of cultures, and optimal lighting and temperature conditions),
establishment of cultures with a high degree of organogenesis (shoot, root cultures), application of
biotic or abiotic elicitors, and genetic transformation (e.g., hairy root cultures). Increasing the biomass
production and the scale-up of cultures’ production in the special plant bioreactors are also important
aspects of biotechnology studies [111,114,115].
The growing interest in the beneficial values of I. tinctoria has been concentrated mainly on the
roots of this plant as the best source of demanding metabolites. As apparent from the analysis of
the latest scientific literature, the biotechnological studies on I. tinctoria are limited mainly to hairy
root cultures. Interestingly, within the last four years, the teams of two researchers: Gai and Jiao
from Northeast Forestry University, Harbin in China, have published a series of research publications
on I. tinctoria hairy root cultures. The cultures were successfully initiated from in vitro petiole
explants co-cultured with Agrobacterium rhizogenes with the addition of acetosyringone and arginine.
In the obtained hairy root cultures, the high production of alkaloids [116] and flavonoids [117] was
confirmed. Within the alkaloids epigoitrin, isatin, indole-3-carboxaldehyde, tryptanthrin, indigo, and
indirubin were qualitatively and quantitatively determined by LC–MS/MS. The total alkaloid content
(521.77 µg/g DW (dry weight)) was 1.12 times higher than in two-year-old roots of field grown plants
(464.69 µg/g DW) [116]. Under the study on flavonoid composition, eight bioactive constituents were
estimated by the LC-MS/MS method: rutoside, neohesperidin, buddleoside, liquiritigenin, quercetin,
isorhamnetin, kaempferol, and isoliquiritigenin [117]. Under optimal conditions, the total flavonoid
content (438.10 µg/g DW) was found to be 1.28 times higher than in two-year-old field grown roots
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(341.73 µg/g DW) analyzed for comparison. Additionally, in vitro antioxidant assays demonstrated
that hairy root extracts exhibited higher activities than those from roots of field grown plants [117].
Such promising results prompted the Chinese team to perform the elicitation experiments on
these cultures in order to boost the bioactive metabolites’ production. The elicitation experiment with
chitosan was proven to increase the flavonoid yield in I. tinctoria hairy root biomass [118]. In comparison
with the control (2.31 mg/g DW), a 7.08-fold enhancement of total flavonoids (16.35 mg/g DW) was
achieved in 24-day-old hairy root cultures elicited by 150 mg/L chitosan for 36 h [118]. Under another
study, the I. tinctoria hairy root cultures were exposed to ultraviolet radiation (UV-A, UV-B, and UV-C)
in an attempt to promote the production flavonoids. Results showed that the maximum flavonoid
accumulation (7259.12 µg/g DW) in hairy root cultures treated by 108 kJ/m2 dose of UV-B radiation
increased 16.51-fold as compared to the control (439.68 µg/g DW) [119]. Moreover, the same teams
proved the increase of flavonoid production after I. tinctoria hairy root cultures co-cultivation with
two immobilized live GRAS (Generally Recognized as Safe) fungi: Aspergillus niger and Aspergillus
oryzae. A. niger strains were exhibited as the better biotic elicitor in the plant-fungus co-cultivation
system. The highest flavonoid production (3018.31 µg/g DW) was achieved after treatment with
spores at the concentration of ca.104 spores/mL, temperature of 30 ◦C, pH 7.0, and time of 72 h. The
total amount of flavonoids increased 6.83 times in comparison to control hairy roots (441.91 µg/g
DW) [120]. A recent work on elicitation of I. tinctoria hairy root cultures proved enhanced production
of flavonoids as well as alkaloids after abiotic elicitation protocol applied with salicylic acid and methyl
jasmonate [121]. As determined by central composite design based on a mathematical model, the
maximum accumulation of alkaloids was found in biomass elicited by 142.61 µM salicylic acid for
28.18 h and flavonoids in biomass elicited by 179.54 µM methyl jasmonate for 41.87 h. These amounts
increased 5.89-times and 11.21-times, respectively, in comparison with the control.
The above described biotechnological studies on I. tinctoria hairy roots are a good example of
the importance of optimization culture conditions, aimed at high secondary metabolites’ production.
Authors claim that their research studies are a promising and effective approach for the enhanced
production of flavonoids and alkaloids in I. tinctoria in vitro cultures, which allows for the improved
applicability of these valuable compounds in pharmaceutical fields, and that their studies pave the
way toward the successful commercialization of this culture system in the future.
In the available scientific literature, there is only one publication on the development of the
micropropagation protocol for I. tinctoria, based on the adventitious shoot regeneration method. Under
the work of Saglam and Ciftci [122], the effective shoot regeneration system was developed using
‘isubgol’ as a cheap alternative gelling substance. The leaf and hypocotyl explants were cultured on
Murashige and Skoog (MS) [123] medium solidified with 6.5 g/L agar or 15 g/L isubgol containing
different concentrations of BA (6-benzyladenine) and NAA (1-naphthaleneacetic acid). Maximum
regeneration of 12.65 and 17.80 shoots per leaf explant was observed on MS medium solidified with
agar containing 1 mg/L BA with 0.25 mg/L NAA and on MS medium solidified with isubgol containing
0.50 mg/L BA, respectively. Maximum regeneration of 19.87 and 20.55 shoots per hypocotyl explant on
agar and isubgol gelled media was recorded on MS medium containing 0.50 mg/L BA with 0.25 mg/L
NAA, and 1 mg/L BA, respectively. The gelling agent Isubgol gave better shoot regeneration as
compared to agar.
In the existing literature, only one study on shoot cultures of I. tinctoria is available. In particular,
Reference [124] obtained the establishment of I. tinctoria shoot cultures starting from the nodal
segments of young plants cultured on MS and Gamborg (B5) [125] media supplemented with BA
or KIN (kinetin) with or without NAA. The best multiplication rates were obtained on B5 medium
supplemented with 1 mg/L BA (3.4 shoots per explant). The addition of NAA to the tested media did
not increase multiplication.
Currently, under the cooperation of our teams, from the Department of Chemical, Biological,
Pharmaceutical and Environmental Sciences, University of Messina (Messina, Italy), and the Department
of Pharmaceutical Botany, Jagiellonian University, Collegium Medicum (Kraków, Poland), in vitro
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shoot cultures of I. tinctoria have been successfully initiated, which aimed to investigate whether they
could represent a potential source of bioactive compounds (Figure 8) [unpublished]. The cultures
were successfully initiated from the seeds, and the preliminary media composition optimization was
performed. The MS media variants with BA and KIN as cytokinins and NAA and IBA (indole-3-butyric
acid) as auxins in different concentrations (range from 0 to 2 mg/L) were tested. The best conditions for
agar shoot cultures were proven to be MS medium containing 1 mg/L BA and 1 mg/L NAA on which
the biomass increment was equal to 3.58-fold (fresh weight).
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7. C nclusio s
I. tinctoria has an ancient and well-documented history as an indigo dye and medicinal plant. It has
been long utilized as an ornamental crop and an animal feeding plant, and, currently, its importance
increased in cosmetic industry. Due to the relevance of this species, a large number of in vitro and
in vivo investigations carried out on I. tinctoria mostly in the last 20 years have provided reasonable
support for its various traditional uses, which shows that the diverse extracts or compounds isolated
from different parts of this species have a broad spectrum of biological activities. As far as we know,
there is only one previous review article by Hamburger (2002), which reported studies published
from 2000 to 2002 focusing only on the anti-inflammatory activity of I. tinctoria extract and its active
component tryptanthrin.
This article review provides an up-to-date and comprehensive overview mainly on the
phytochemistry and the biological properties demonstrated for this valuable species in order to
support its therapeutic potential and to offer input for future research prospects.
The article also focuses on all attempts in plant biotechnology studies for the enhanced production
of bioactive compounds from I. tinctoria hairy root and shoot cultures as an alternative to plant raw
materials. Plant in vitro culture technology has emerged as an attractive alternative for the field
cultivation of I. tinctoria. Due to the high therapeutic value of I. tinctoria, the biotechnological approach
represents a promising way to develop safe and more effective extracts than traditional ones. The
large-scale production of biotechnological extracts, enriched in desired metabolites and obtained by
different in vitro systems, should become the goal of further scientific studies.
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